Company Search:
Advanced Search
Sponsored Links
Biofermin Pharmaceutical Company Limited Company Snapshot
Biofermin Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofermin Pharmaceutical Company Limited with three other pharmaceutical manufacturers in Asia: Astrazeneca Pharma India Ltd of India (2016 sales of 5.64 billion Indian Rupees [US$84.50 million] of which 98% was Healthcare), Sequent Scientific Limited of India (6.34 billion Indian Rupees [US$95.11 million] of which 99% was Pharmaceuticals), and Ind-Swift Laboratories Limited which is also based in India (6.53 billion Indian Rupees [US$97.92 million] ).

Sales Analysis. Biofermin Pharmaceutical Company Limited reported sales of ¥9.67 billion (US$92.80 million) for the fiscal year ending March of 2016. This represents a decrease of 10.9% versus 2015, when the company's sales were ¥10.85 billion. The sales level in 2016 was fairly close to the level five years ago: in 2011, Biofermin Pharmaceutical Company Limited had sales of ¥9.07 billion. Contributing to the drop in overall sales was the 30.0% decline in Biofermin Synthetic Drugs, from ¥1.14 billion to ¥796.78 million. There were also decreases in sales in New Biofermins (down 7.3% to ¥5.96 billion) and Biofermin Tablet (down 6.6% to ¥1.58 billion) and Bioferminr (down 27.3% to ¥673.73 million) and Other (down 0.7% to ¥657.40 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biofermin Pharmaceutical Company Limited
  Stock Performance Chart for Biofermin Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 2,629.00
(Figures in Japanese Yen)
1 Week -0.3%   13 Weeks -2.1%  
4 Weeks -6.4%   52 Weeks -21.5%  
Biofermin Pharmaceutical Company Limited Key Data:
  Ticker: 4517 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 9,666,222,000
(Year Ending Jan 2017).
Employees: 177
  Currency: Japanese Yen Market Cap: 31,396,890,338
  Fiscal Yr Ends: March Shares Outstanding: 11,942,522
  Share Type: Common Closely Held Shares: 8,027,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.